A2A at Biopharma

A2A participated at the AI Applications Summit Biopharma discussing the urgency to advance AI applications in industry to bring benefits to patients faster

LEARN MORE

A2A Panelist

A2A Founder & CEO Edward Painter was a panelist at BIO Investor forum panel entitled "Applying artificial intelligence to improve therapy development today"

LEARN MORE

Fierce Biotech

Insilico and A2A launched new Deuchenne-focused AI drug company

LEARN MORE